Name: Isolation and Validation of Podoplanin-positive Mesenchymal Stem Cell Subpopulations Using an Indirect Magnetic Bead Strategy (Video) | JoVE Journal
Uploaded: 2026-06-23T14:00:00.000+00:00
Duration: 8 min 18 s
Description: Learn to isolate podoplanin-positive mesenchymal stem cell subpopulations using an indirect magnetic bead strategy with PE-labeled antibodies. This cost-effective method achieves high purity without flow cytometric sorters.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We would like to express our gratitude to Professor Bian Liming and Professor Zhang Kunyu from the School of Biomedical Sciences and Engineering, International Campus, South China University of Technology, for providing the experimental platform and guidance. This work was funded by the China Postdoctoral Science Foundation (2023M734022), the GuangDong Basic and Applied Basic Research Foundation (2023A1515111162), and the National Natural Science Foundation of China (82502983).

Human bone marrow-derived MSCs were commercially obtained (see the Table of Materials). The supplier confirmed MSC identity by positive expression of CD73, CD90, and CD105; negative expression of CD34, CD45, and HLA-DR; and trilineage differentiation potential. Cells were expanded in culture and used at passages 3&#8211;5. All human-derived cell work was performed in a Class II biological safety cabinet under sterile conditions. As the cells were commercially acquired and no human subjects were directly recruited or sampled in this protocol, no direct IRB approval was required.
1. Preparation of single-cell suspension
NOTE: The quality of the single-cell suspension directly affects the sorting efficiency. Ensure cells are well-dispersed, highly viable, and free of clumps. Visible clumps should be dispersed by repeated gentle pipetting until clumps are no longer visible.
<ol>
	<li>Select MSCs (passages 3&#8211;5) that have reached 80&#8211;90% confluence. Discard the culture medium.</li>
	<li>Wash the cells with 2 &#215; 10 mL of prewarmed PBS. Gently rock the vessel and discard the PBS.</li>
	<li>Add 2 mL of 0.25% Trypsin-EDTA and incubate at 37 &#176;C for 3&#8211;5 min. Observe the cells under a microscope until they round up and begin to detach.</li>
	<li>Add 4 mL of culture medium containing 16.5% FBS (see the Table of Materials) to neutralize the trypsin. Gently pipette the cells to ensure complete detachment. Transfer the cell suspension to a 15 mL centrifuge tube. 
	NOTE: Check under the microscope to confirm that all cells have been collected.</li>
	<li>Centrifuge at 300 &#215; g for 3 min and discard the supernatant.</li>
	<li>Resuspend the cell pellet in 1 mL of Buffer (see the Table of Materials). Proceed to cell counting.</li>
</ol>
2. Cell counting and concentration adjustment
NOTE: If the total cell number is less than 1 &#215; 107, still add the antibody and magnetic reagents based on the standard volume for 1 &#215; 107 cells to ensure labeling efficiency.
<ol>
	<li>Centrifuge the cell suspension again at 300 &#215; g for 3 min and discard the supernatant.</li>
	<li>Resuspend the cells in Buffer to achieve a density of 1 &#215; 108 cells/mL. 
	NOTE: For example, to process 1 &#215; 107 cells, resuspend the pellet in 100 &#181;L of buffer.</li>
	<li>Transfer the cell suspension to a 5 mL polystyrene round-bottom tube.</li>
</ol>
3. Antibody labeling
<ol>
	<li>Add 10 &#181;L of Fc gamma RII Blocker (see the Table of Materials) per 1 &#215; 107 cells. Mix gently and incubate at room temperature for 10 min.</li>
	<li>Add 5 &#181;L of PE-conjugated anti-human PDPN antibody (see the Table of Materials) per 1 &#215; 107 cells, following the manufacturer&#39;s recommended concentration. Mix gently and incubate at room temperature for 15&#8211;20 min, protected from light. 
	NOTE: The antibody volume should be adjusted according to the datasheet of the specific flow cytometry antibody being used, as concentrations may vary between products.</li>
</ol>
4. Magnetic bead labeling
NOTE: Keep all reagents on ice before use and return them to ice immediately after each addition to maintain activity and consistency.
<ol>
	<li>Add 10 &#181;L of Selection Cocktail per 1 &#215; 107 cells (see the Table of Materials). Mix gently and incubate at room temperature for 15 min.</li>
	<li>Add 5 &#181;L of magnetic beads per 1 &#215; 107 cells (see the Table of Materials). Mix gently and incubate at room temperature for 10 min. 
	NOTE: Vortex the magnetic beads vial vigorously for 30 s before use to ensure even dispersion.</li>
</ol>
5. Magnetic separation
<ol>
	<li>Place a 5 mL polystyrene round-bottom tube containing the labeled cell sample in the magnetic separation stand (see the Table of Materials).</li>
	<li>Add buffer to the tube to bring the total volume to 2.5&#8211;3 mL. Incubate for 5 min at room temperature.</li>
	<li>Perform the separation: Holding the magnet and tube together as one unit, invert them to pour the supernatant into a new collection tube. This collected fraction contains the PDPN-negative cells; keep this tube on ice. 
	NOTE: Do not remove the tube from the magnetic stand during this step, as this will disrupt the separation and cause the procedure to fail.</li>
	<li>Repeat steps 5.1&#8211;5.3 3x. Each time, add buffer to the original tube in the magnet, wait 5 min, and pour the supernatant into the same negative fraction collection tube used in step 5.4.</li>
	<li>After the final wash, remove the tube containing the magnetically bound cells from the stand. This tube contains the PDPN-positive cell fraction.</li>
	<li>Add 3 mL of buffer to resuspend the positive cells. Transfer this suspension to a fresh, labeled tube (the positive fraction tube).</li>
</ol>
6. Collection, culture, and validation of target cells
<ol>
	<li>Count the cells from both the positive and negative fraction tubes. Record the cell yield for each fraction.</li>
	<li>Centrifuge the positive fraction cell suspension at 300 &#215; g for 3 min. Discard the supernatant.</li>
	<li>Resuspend the cell pellet in MEM Alpha culture medium containing 16.5% FBS. Adjust the cell density as needed and seed the cells into culture plates or flasks.</li>
	<li>Incubate the cells at 37 &#176;C in a 5% CO&#8322; incubator.</li>
</ol>
7. Sample preparation for purity and functional validation
<ol>
	<li>Count the cells and seed them onto a 100 mm culture dish at a density of 3 &#215; 106 cells per dish in 12 mL of culture medium. Twenty-four hours after seeding, observe cell attachment. Replace the culture medium with fresh medium to remove any residual magnetic beads and non-adherent cells.</li>
	<li>Harvest the cells by trypsinization. Gently pipette up and down 10&#8211;15x to dislodge and remove magnetic beads and residual antibodies.</li>
	<li>Assess the percentage of PDPN-PE-positive cells by flow cytometry (see Supplemental File 1 for the detailed protocol).</li>
	<li>Collect cells during the logarithmic growth phase. Seed them into a 96-well plate. At different time points (0 h, 24 h, 48 h, 72 h), add CCK-8 reagent (see the Table of Materials) and measure the absorbance according to the manufacturer&#39;s instructions. Plot a proliferation curve based on the data.</li>
</ol>

The authors have no conflicts of interest to declare.

In this study, we established a magnetic bead-based protocol for isolating PDPN+ cells from bone marrow-derived MSCs. This approach enables efficient enrichment of the PDPN-positive subpopulation while maintaining CCK-8-based proliferation/metabolic activity under the tested conditions.
Compared with conventional direct immunomagnetic sorting methods, the most significant advantage of this strategy lies in its versatility. Traditional approaches require the development or customization of spec...

In the field of orthopedics, injuries such as cartilage damage and lesions in the avascular zone (white zone) of the meniscus often result in irreversible joint destruction and loss of function, ultimately leading to osteoarthritis. This is largely attributable to the poor regenerative capacity of these tissues, which stems from a lack of direct blood and lymphatic supply, as well as the presence of highly differentiated cells with limited capacity for proliferation and migration1,2,3,4. To address this challenge, various clinical strategies have been explored, including the use of exosomes5,6, autologous or allogeneic chondrocyte transplantation7,8, and tissue engineering approaches9,10,11,12. In recent years, mesenchymal stem cells (MSCs) have emerged as a promising cell source for regenerative repair, owing to their multilineage differentiation potential and immunomodulatory properties, offering new hope for cartilage regeneration13,14,15,16.
Despite their therapeutic potential, MSCs exhibit significant heterogeneity. Even within a single tissue source, such as bone marrow or umbilical cord, distinct subpopulations of MSCs can display considerable variability in proliferation capacity, multilineage differentiation potential (particularly chondrogenic differentiation), and in vivo regenerative function17,18,19. Therefore, the precise identification and isolation of functionally defined MSC subpopulations&#8212;such as those with enhanced chondrogenic capacity&#8212;is essential for advancing our understanding of their biological properties and improving the efficacy of cartilage repair. This represents a critical step in our research.
As research progresses, an increasing number of novel membrane proteins have been identified as markers of functionally distinct MSC subpopulations. However, translating these discoveries into effective cell sorting strategies remains technically challenging. Conventional fluorescence-activated cell sorting (FACS), while powerful, requires specialized instrumentation and technical expertise, limiting its accessibility in many laboratories. On the other hand, immunomagnetic cell sorting&#8212;though more widely used&#8212;is constrained by the limited availability of commercial reagents, which are primarily designed for a few well-established membrane targets. Consequently, for many newly discovered markers with potential biological significance, there are no commercially available magnetic beads, making it difficult to specifically enrich these valuable MSC subpopulations.
To overcome this limitation, the present study aims to establish and standardize a flexible, cost-effective, and efficient protocol for positive cell selection. This approach is based on the indirect conjugation of commercially available phycoerythrin (PE)-conjugated antibodies with anti-PE immunomagnetic beads. Previous reports have demonstrated that podoplanin-positive (PDPN+) MSCs possess superior stemness maintenance and differentiation capacity compared to their PDPN- counterparts20. Furthermore, the involvement of PDPN+ MSCs in cartilage regeneration and the progression of osteoarthritis (OA) has been documented in the literature21,22. Using podoplanin (PDPN)&#8212;a recently identified candidate marker of functional MSC subpopulations&#8212;as a model target, we sorted PDPN-positive cells from bone marrow-derived MSCs. We provide a detailed step-by-step protocol covering single-cell suspension preparation, antibody and magnetic bead labeling, and magnetic separation. Moreover, we evaluate the yield, post-sort PDPN positivity, and CCK-8-based proliferation/metabolic activity of the sorted cells. By standardizing this protocol, we aim to provide researchers with a versatile, accessible method for isolating target cell subpopulations using compatible antibodies against accessible cell-surface markers, thereby facilitating fundamental stem cell research and future translational applications in regenerative medicine.

<table><tbody><tr><td>7-AAD Cell Viability Assay Kit</td><td>KeyGEN</td><td>KGD1202-50</td><td></td></tr><tr><td>Anti-human CD32 Blocker (Fc gamma RII Blocker)</td><td>STEMCELL Technologies</td><td>18520</td><td></td></tr><tr><td>Buffer</td><td>STEMCELL Technologies</td><td>20104</td><td>Buffer</td></tr><tr><td>CCK-8</td><td>Meilunbio</td><td>MA0218-5</td><td></td></tr><tr><td>Dextran Magnetic Particles</td><td>STEMCELL Technologies</td><td>50100</td><td>Magnetic Particles</td></tr><tr><td>Fetal Bovine Serum</td><td>Gibco</td><td>16050-122</td><td></td></tr><tr><td>Magnet</td><td>STEMCELL Technologies</td><td>18000</td><td>magnetic separation stand</td></tr><tr><td>MEM Alpha Medium</td><td>Gibco</td><td>C12571500BT</td><td>MEM Alpha Medium (82.5%) + FBS (16.5%) + Penicillin-Streptomycin (1.0%)</td></tr><tr><td>MSCs</td><td>KeyGEN</td><td>KGG5575-1</td><td>Human bone marrow-derived mesenchymal stem cells</td></tr><tr><td>PE-conjugated Anti-Human PDPN Antibody</td><td>ABclonal</td><td>A26770</td><td>PDPN-PE</td></tr><tr><td>PE Selection Cocktail</td><td>STEMCELL Technologies</td><td>18151</td><td>Selection Cocktail</td></tr><tr><td>Penicillin-Streptomycin</td><td>Gibco</td><td>15140122</td><td></td></tr><tr><td>Trypsin-EDTA</td><td>Gibco</td><td>25200-072</td><td></td></tr></tbody></table>

isolation and validation of podoplanin-positive mesenchymal stem cell subpopulations using an indirect magnetic bead strategy

Isolation and Validation of Podoplanin-positive Mesenchymal Stem Cell Subpopulations Using an Indirect Magnetic Bead Strategy

The study of functional heterogeneity in mesenchymal stem cells relies on the efficient isolation of specific subpopulations (e.g., podoplanin (PDPN)-positive cells). However, for most membrane protein targets, directly available commercial magnetic beads for sorting are limited. To address this, our laboratory has established and tested a standardized magnetic bead sorting protocol based on the indirect coupling principle of &#34;phycoerythrin (PE)-labeled flow cytometry antibodies/anti-PE magnetic beads.&#34; Using PDPN-positive cells as a model target population, this protocol enriches a target cell fraction without relying on expensive flow cytometric cell sorters.
Researchers can use compatible PE-labeled flow cytometry antibodies targeting accessible cell-surface proteins and combine them with commercially available anti-PE microbeads to establish a sorting workflow for selected targets after target-specific optimization. This approach avoids the lengthy lead times and high costs associated with customizing or ordering target-specific magnetic beads for each new target, making it particularly suitable for accessible surface markers that are rare or understudied. In the PDPN model system tested here, the protocol enabled enrichment of the target subpopulation with high post-sort PDPN positivity and preserved CCK-8-based proliferation/metabolic activity compared with unsorted MSCs.

The overall principle and workflow of the experiment are illustrated in Figure 1. All subsequent experimental data are based on passage 5 cells. Following magnetic separation, the obtained PDPN+ cells were cultured for 24–48 h. After replacing the culture medium to remove non-adherent cells and potential residual magnetic beads (Figure 2A), we evaluated the sorting efficiency and cell yield. Starting with an initial population of 1 × ...

This protocol describes a magnetic bead-based sorting method using phycoerythrin (PE)-labeled flow cytometry antibodies and anti-PE microbeads to isolate specific mesenchymal stem cell subpopulations with high postsort target-marker positivity and preserved CCK-8-based proliferation/metabolic activity under the tested conditions, without requiring expensive cell sorters or target-specific custom beads.

The study of functional heterogeneity in mesenchymal stem cells relies on the efficient isolation of specific subpopulations (e.g., podoplanin ...

Our research focused on isolating specific mesenchymal stem cell subset for cost-effective magnetic bead softening with high purity and readability. This protocol can be applied to any membrane protein using standard PE conjugated antibodies. To begin, gather the required reagents.Select mesenchymal stem cells, or MSCs, from passages three to five that have reached 80 to 90%confluence. Discard the culture medium. Wash the cells twice with 10 milliliters of pre-warmed PBS.Gently rock the vessel and discard the PBS. Add two milliliters of 0.25%trypsin-EDTA and incubate at 37 degrees Celsius for three to five minutes. Under a microscope, observe the cells until they round up and begin to detach.Add four milliliters of culture medium containing 16.5%FBS to neutralize the trypsin. Gently pipette the cells to ensure complete detachment and transfer the cell suspension to a 15-milliliter centrifuge tube. Centrifuge the cell suspension at 300 g for three minutes and discard the supernatant.Re-suspend the cell pellet in one milliliter of buffer. Count the cells to determine the total cell number. Centrifuge and discard the supernatant as previously demonstrated.Re-suspend the cells with buffer to achieve a density of 100 million cells per milliliter. Transfer the cell suspension to a five milliliter polystyrene round-bottom tube. Add 10 microliters of Fc gamma RII blocker per 10 million cells.Mix gently and incubate at room temperature for 10 minutes. Add five microliters of phycoerythrin conjugated, or PE conjugated, antihuman podoplanin, or PDPN antibody, per 10 million cells. Mix gently and incubate at room temperature for 15 to 20 minutes protected from light.Add 10 microliters of selection cocktail per 10 million cells. Mix gently and incubate at room temperature for 15 minutes. Use a vortex mixer to mix the magnetic beads vial vigorously for 30 seconds.Add five microliters of magnetic beads per 10 million cells. Mix gently and incubate at room temperature for 10 minutes. Place the five milliliter polystyrene round-bottom tube containing the labeled cell sample in the magnetic separation stand.Add buffer to the tube to bring the total volume to 2.5 to three milliliters. And incubate at room temperature for five minutes. Holding the magnet and tube together as one unit, invert them to pour the supernatant into a new collection tube.Place the collected PDPN negative cell fraction on ice. Repeat the magnetic separation procedure three times as previously demonstrated, pouring the supernatant into the same PDPN negative fraction collection tube after each separation. After the final wash, remove the tube containing the magnetically bound PDPN positive cell fraction from the magnetic separation stand.Add three milliliters of buffer to re-suspend the positive cells. Transfer the positive fraction cell suspension to a fresh-labeled tube. Count the cells from both the positive and negative fraction tubes.Record the cell yield for each fraction. Centrifuge the positive fraction cell suspension at 300 g for three minutes and discard the supernatant. Re-suspend the cell pellet in MEM alpha culture medium containing 16.5%FBS.Adjust the cell density as needed and seed the cells into culture plates or flasks. Incubate the cells at 37 degrees Celsius in a 5%carbon dioxide incubator. After counting the cells, seed them onto a 100-millimeter culture dish at a density of three million cells per dish in 12 milliliters of culture medium.24 hours after seeding, observe cell attachment. Replace the culture medium with fresh medium to remove residual magnetic beads and non-adherent cells. Harvest the cells by trypsinization.Gently pipette the cell suspension up and down 10 to 15 times to dislodge and remove magnetic beads and residual antibodies. Assess the percentage of PDPN PE-positive cells by flow cytometry. Collect cells during the logarithmic growth phase.Seed the cells into a 96-well plate. At different time points, add Cell Counting Kit-8m or CCK-8, reagent and measure absorbance according to the manufacturer's instructions. Tabulate the pre-sort and post-sort data for different time points in GraphPad Prism software, then click on data to plot the proliferation curve.Following FC receptor blocking, antibody labeling, and magnetic separation, the final cell count was approximately 3.5 million cells for the PDPN positive fraction and 6.4 million cells for the PDPN negative fraction. Before magnetic sorting, the frequency of PDPN positive cells in the starting cell population was 38.7%After sorting, the positive fraction contained 97.9%PDPN PE-positive cells. Flow cytometry analysis of the negative fraction revealed that 4.30%of PDPN positive cells remained, indicating efficient depletion of PDPN positive cells from the negative fraction.The proliferation curve of PDPN positive cells over three consecutive days of culture showed no significant difference compared to unsorted MSCs, indicating that the sorting strategy did not cause a detectable reduction in CCK-8-based proliferation or metabolic activity compared to unsorted MSCs. This approach enable research to study subpopulation with high purity and readability. The most important consideration in this protocol is gentle to maintain cell readability and remove unbound beads.Follow this procedure, research can perform proliferation assays, follow sedimentary and deflation studies.

isolation-validation-podoplanin-positive-mesenchymal-stem-cell

Research

JoVE Journal

Biology

Rat MSCs were isolated from femurs and tibias and then enriched by magnetic cell sorting. Sorted cells were confirmed for the expression of surface markers by flow cytometry. These cells were also cultured at clonal density to form single colonies and then these colonies were separated by cloning cylinders.

Isolation and Enrichment of Rat Mesenchymal Stem Cells (MSCs) and Separation of Single-colony Derived MSCs

A method to analyse the distribution of bone marrow hematopoietic progenitors in flow cytometry as well as to efficiently isolate highly purified hematopoietic stem cells (HSCs) is described. The isolation procedure is essentially based on magnetic enrichment of c-Kit+ cells and cell sorting to purify HSCs for cellular and molecular studies.

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

This article describes the preparation of freshly obtained melanoma tissue into primary cell cultures, and how to remove contaminations of erythrocytes and fibroblasts from the tumor cells. Finally, we describe how CD133+ putative melanoma stem cells are sorted from the CD133- bulk using Magnetic Activated Cell Sorting (MACS).

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

The immunomodulatory properties of human mesenchymal stem cells (MSC) appear increasingly relevant for clinical application. Using a co-culture system of MSCs and peripheral blood leukocytes pre-stained with the fluorescent dye carboxyfluorescein succinimidyl ester (CFSE), we describe the in vitro assessment of MSC immunomodulation on effector leukocyte proliferation and specific subpopulations.

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Human cardiac tissue harbours multipotent perivascular precursor cell populations that may be suitable for myocardial regeneration. The technique described here allows for the simultaneous isolation and purification of two multipotent stromal cell populations associated with native blood vessels, i.e. CD146+CD34- pericytes and CD34+CD146- adventitial cells, from the human myocardium.

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

This article presents a simple and economic protocol for the straightforward isolation and purification of mesenchymal stem cells from New Zealand white rabbit synovial fluid.

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

This protocol illustrates a safe and efficient procedure to modify CD133+ hematopoietic stem cells. The presented non-viral, magnetic polyplex-based approach may provide a basis for the optimization of therapeutic stem cell effects as well as for monitoring the administered cell product via magnetic resonance imaging.

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

We demonstrate how to identify and isolate 6 subsets of myeloid progenitors from murine bone marrow using a combination of magnetic and fluorescence sorting (MACS and FACS). This protocol can be used for in vitro culture assays (methylcellulose or liquid cultures), in vivo adoptive transfer experiments, and RNA/protein analyses.

Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow

This protocol describes the use of fluorescence-activated cell sorting of human mesenchymal stem cells using the single-cell sorting method. Specifically, the use of single-cell sorting can achieve 99% purity of the immunophenotyped cells from a heterogeneous population when combined with a multiparametric flow cytometry-based approach.

Single-Cell Sorting of Immunophenotyped Mesenchymal Stem Cells from Human Exfoliated Deciduous Teeth

This study has established a stable and efficient method for the isolation, culture, and functional determination of vascular wall-resident CD34+ stem cells (CD34+ VW-SCs). This easy-to-follow and time-effective isolation method can be utilized by other investigators to study the potential mechanisms involved in cardiovascular diseases.

Immunomagnetic Isolation of the Vascular Wall-Resident CD34+ Stem Cells from Mice

Learn to isolate podoplanin-positive mesenchymal stem cell subpopulations using an indirect magnetic bead strategy with PE-labeled antibodies. This cost-effective method achieves high purity without flow cytometric sorters.

Isolation and Validation of Podoplanin-positive Mesenchymal Stem Cell Subpopulations Using an Indirect Magnetic Bead Strategy

Explore More Videos